News - Page 156 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and Receives a Favorable Patent Claim Opinion

Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and Receives a Favorable Patent Claim Opinion

Post published:August 17, 2021
Post category:Press Release

Read more about the article MindMed Joins Critical Path Institute’s Patient-Reported Outcome Consortium

MindMed Joins Critical Path Institute’s Patient-Reported Outcome Consortium

Post published:August 17, 2021
Post category:Press Release

Read more about the article Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer

Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer

Post published:August 17, 2021
Post category:Press Release

Read more about the article Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update

Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update

Post published:August 17, 2021
Post category:Press Release

Read more about the article Filament Health Announces Q2 2021 Financial Results

Filament Health Announces Q2 2021 Financial Results

Post published:August 16, 2021
Post category:Press Release

Read more about the article PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of Methylated Trypatamines and Associated Analogs

PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of Methylated Trypatamines and Associated Analogs

Post published:August 16, 2021
Post category:Press Release

Read more about the article Mindset Pharma Announces Publication of Three PCT Patent Applications for Its Next Generation Psychedelic Drug Candidates

Mindset Pharma Announces Publication of Three PCT Patent Applications for Its Next Generation Psychedelic Drug Candidates

Post published:August 16, 2021
Post category:Press Release

Read more about the article atai Life Sciences Reports Second Quarter 2021 Financial Results and Business Update

atai Life Sciences Reports Second Quarter 2021 Financial Results and Business Update

Post published:August 16, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results

Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results

Post published:August 16, 2021
Post category:Press Release

Read more about the article Beckley Psytech completes oversubscribed $80m (£58m) fundraise to develop portfolio of psychedelic medicine breakthroughs

Beckley Psytech completes oversubscribed $80m (£58m) fundraise to develop portfolio of psychedelic medicine breakthroughs

Post published:August 16, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.